Hims & Hers Health, Inc. (HIMS) vs Rhythm Pharmaceuticals, Inc. (RYTM)

A side-by-side comparison of Hims & Hers Health, Inc. and Rhythm Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — HIMS vs RYTM

growth of $100 · dividends reinvested · last 7y
HIMS +195.9% (+16.8%/yr)RYTM +303.0% (+22.0%/yr)RYTM compounded faster over this window
0200400600Start $100202120232025$296$403
HIMS RYTM

HIMS vs RYTM: by the numbers

  • •HIMS is the larger company ($6.57B vs $6.23B market cap).
  • •Both run net losses; HIMS's is the smaller (-5.51% vs -85.59% net margin).
  • •RYTM grew revenue faster over the past five years (278.53% vs 67.47% CAGR).

Metrics side by side

Valuation

MetricHIMSRYTM
P/S ratio2.5525.95
P/B ratio20.2960.46
FCF yield1.37%N/A

Profitability

MetricHIMSRYTM
Gross margin73.84%89.00%
Operating margin4.50%-101.19%
Net margin-5.51%-85.59%
ROE-43.83%-94.50%
ROIC-4.30%-63.96%

Growth (annualized)

MetricHIMSRYTM
Revenue CAGR (5Y)67.47%278.53%
Total return CAGR (5Y)31.98%49.95%

Frequently asked

Which has grown faster, HIMS or RYTM?
Over the past five years, RYTM grew revenue faster — HIMS at a 67.47% CAGR versus RYTM at 278.53%.
How have HIMS and RYTM total returns compared?
Over the past 5 years, HIMS delivered 31.98% and RYTM delivered 49.95% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.